(Q37930063)

25 August 2017

1 reference

title

Reperfusion therapy in acute myocardial infarction: present status and controversy (English)

1 reference

25 August 2017

main subject

myocardial infarction

1 reference

acute myocardial infarction

inferred from title

1 reference

Mueller HS

1

1 reference

25 August 2017

publication date

1 April 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

239-246

1 reference

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intracoronary thrombolysis in evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Non surgical coronary artery recanalization in acute transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intracoronary infusion of streptokinase in patients with acute myocardial infarction: Effects of reperfusion on left ventricular performance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intracoronary thrombolysis in acute myocardial infarction: correlations among serum enzyme, scintigraphic and hemodynamic findings

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intravenous urokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Clot-selective coronary thrombolysis with pro-urokinase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

GISSI trial: early results and late follow-up. Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto Miocardico

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Update from the Thrombolysis in Myocardial Infarction Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

"High-risk" percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Expansion of acute myocardial infarction: an experimental study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Reduced frequency of ventricular fibrillation after early thrombolysis in myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960130403

7 January 2021

Identifiers

DOI

10.1002/CLC.4960130403

1 reference

25 August 2017

1 reference